Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic

OBJECTIVES: Caring for osteoporosis patients has proven challenging during the COVID-19 pandemic due to repeated lockdowns in Austria. The distinct possibility of insufficient treatment regimens is therefore a matter of pressing concern. The aim of the study was to assess alterations in dispensing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocijan, Roland, Stockinger, Theresa, Haschka, Judith, Reichardt, Berthold, Resch, Heinrich, Zwerina, Jochen, Behanova, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239920/
https://www.ncbi.nlm.nih.gov/pubmed/35779846
http://dx.doi.org/10.1016/j.bone.2022.116477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239920/
https://www.ncbi.nlm.nih.gov/pubmed/35779846
http://dx.doi.org/10.1016/j.bone.2022.116477

Ejemplares similares